It's a difficult call, but I'm Reiterating my Buy rating for Cardinal Health (NYSE: CAH), first recommended on April 21, 2009 at a price of $33.52.

Cardinal Health has meandered since April, despite generally favorable investor reviews of CAH's plan to spin-off its clinical medical products segment in mid-2009, to be called CareFusion Corp., allowing Cardinal to focus on revitalizing its health care supply chain services business, which recently returned to profitability.

It goes without saying that this market remains a stock picker's market. Select the wrong stock, and there's a 30-40% haircut up ahead; select the correct stock, and you're positioned for the recovery with modest downside exposure. For a chance at the latter, consider Cardinal Health (NYSE: CAH).

In general, analysts view CAH's filing to spin-off its clinical medical products segment in mid-2009 as allowing Cardinal to focus on revitalizing its health care supply chain services business, which recently returned to profitability.

Hansen Medical (NASDAQ: HNSN) said economic conditions have led to lower than expected Q4 sales. HNSN, a developer of products for robotic catheter-based technologies, closed at $6.26. Thomas Weisel Partners has a $8 price target on HNSN. HNSN February call option implied volatility is at 115, puts are at 133, above its 26-week average of 69, according to Track Data, suggesting larger price movement.

Cardinal Health (NYSE: CAH), a drug wholesaler and medical-equipment supplier, lowered its full-year outlook on January 8 because it sees reduced hospital spending. Smith Barney has a 12-month price target of $39 on CAH. February option implied volatility of 49 is above its 26-week average of 41 according to Track Data, suggesting larger price movement.

Becton Dickinson (NYSE: BDX), a medical technology company, closed at $69.11. Morgan Stanley raised its rating on BDX to Overweight. BDX February option implied volatility of 38 is above its 26-week average of 33, according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

This post is part of a series in which TheStockAdvisors.com asked financial experts to name their top stock pick if McCain or if Obama wins the election.

"Should Obama win the election, we would look towards select sub-sectors of health care; one stock we would expect to benefit is health supply distributor, Cardinal Health (NYSE: CAH)," explains Kelley Wright, editor of the blue chip Investment Quality Trends.

"A President Obama will have to make good on his promise to deliver better health care. While this could create havoc for the pharmaceutical producers, drug therapies and medical supplies will have to be delivered.

"The 800lb. gorilla in the supply and distribution space is Cardinal Health. Cardinal is a global company whose distribution businesses consolidate pharmaceuticals and medical products from thousands of manufacturers into site-specific deliveries to retail pharmacies, hospitals, physician's offices, surgery centers and alternate care facilities.

"The company has recently taken steps to increase the percentage of cash flow into dividends and share repurchases to enhance shareholder value.

"The blue chip stocks that we recommend are chosen for the exemplary long-term dividend growth, a P/E ratio of 15 or less, a payout ratio of 50% or less, debt of 50% or less, and technical characteristics on the daily and weekly charts that suggests the potential for imminent capital appreciation.

"While the current dividend yield on Cardinal Health is comparatively low at around 1.0%, the upside potential for capital appreciation is quite large."

Steven Halpern's TheStockAdvisors.com offers a daily look at the latest market commentary and favorite stock picks and investment ideas from the nation's leading financial newsletter advisors.

This post is part of a series in which TheStockAdvisors.com asked financial experts to name their top stock pick if McCain or if Obama wins the election.

Which stocks would benefit from a victory by either Senator John McCain or Senator Barack Obama? To help investors sort through the sectors and stocks best positioned to benefit in a post-election environment, we posed this question to some of the nation's leading financial newsletter advisors.

Importantly, this is not a partisan report; each participating advisor has provided a favorite stock for both candidates, focused not on political preferences but unbiased stock analysis. Below we feature those stocks and ETFs that the advisors believe will be the winners depending on which candidate prevails.

McCain Stocks:

Roger Conrad - Comcast (NYSE: CCW)
Gregg Early - Elbit Systems (NASDAQ: ESLT)
Elliott Gue - Paladin Resources (Toronto: PDN)
Doug Fabian - Market Vectors Nuclear Energy (NYSE: NLR)
Vivian Lewis - Barclays (NYSE: BCS)
Bill Martin - CGG Veritas (NYSE: CGV)'
Yiannis Mostrous - Lonking Holdings (OTC: CIMHF)
Carla Pasternak - Eaton Vance Tax-Advantaged Dividend Income Fund (NYSE: EVT)
Nate Pile - SPDR Gold Trust (NYSE: GLD)
John Reese - General Dynamics (NYSE: GD)
Nathan Slaughter - USEC (NYSE: USU)
Paul Tracy - Shaw Group (NYSE: SGR)
Kelley Wright - CenturyTel (NYSE: CTL)
Tom Vass - Molex (NASDAQ: MOLX)
Martin Hutchinson - Northrop Grumman (NYSE: NOC), Merck & Co. (NYSE: MRK), EOG Resources (NYSE: EOG)

Obama Stocks:

Roger Conrad - SunPower (NASDAQ: SPWR)
Gregg Early - AeroVironment (NASDAQ: AVAV)
Elliott Gue - SunPower (NASDAQ: SPWR)
Doug Fabian - Industrial Select Sector SPDR (NYSE: XLI)
Vivian Lewis - Cosan (NYSE: CZZ)
Bill Martin - Geron (NASDAQ: GERN)
Yiannis Mostrous - Dr. Reddy's (NYSE: RDY)
Carla Pasternak - Kinder Morgan Energy Partners (NYSE: KMP)
Nate Pile - Apple (NASDAQ: AAPL)
John Reese - American Eagle (NYSE: AEO)
Nathan Slaughter - Fluor (NYSE: FLR)
Paul Tracy - Market Vectors Global Alternative Energy (NYSE: GEX)
Kelley Wright - Cardinal Health (NYSE: CAH)
Tom Vass - Ingersoll Rand (NYSE: IR)
Martin Hutchinson - Microsoft (NASDAQ: MSFT), Time Warner Inc. (NYSE: TWX), First Solar (NASDAQ: FSLR)

MOST NOTEWORTHY: WuXi Pharma, ExxonMobil and LifePoint Hospitals were today's noteworthy upgrades:

• Jefferies upgraded shares of WuXi Pharma (NYSE: WX) to Buy from Hold as they believe the risk/reward is much improved following the recent weakness. They think the company's 2008 guidance is achievable.
  
• Credit Suisse raised ExxonMobil (NYSE: XOM) to Outperform from Neutral as they believe the rise in crude oil means analyst estimates are too low.
  
• Goldman sees upside to hospital stocks given low valuations and expectations. The firm upgraded LifePoint Hospitals (NASDAQ: LPNT) to Buy from Neutral and named it a top pick along with previous top pick Cardinal Health (NYSE: CAH).

OTHER UPGRADES:

• Goldman added NDS Group (NASDAQ: NNDS) to their Conviction Buy List and upgraded shares to Buy from Neutral.
  
• Morgan Stanley raised Boeing (NYSE: BA) to Overweight from Equal Weight.
  
• JP Morgan added Sherwin-Williams (NYSE: SHW) to the Focus List.

MOST NOTEWORTHY: DiamondRock Hospitality, Pzena Investment and Vodafone were today's noteworthy upgrades:

• DiamondRock Hospitality (NYSE: DRH) was upgraded to Outperform from Neutral at Baird, citing the newly-announced 4.8M repurchase plan, strong balance sheet and valuation.
  
• Keefe Bruyette upgraded shares of Pzena Investment (NYSE: PZN) to Market Perform from Underperform after the company announced February ending AUM.
  
• Goldman added Vodafone (NYSE: VOD) to its Conviction Buy List following the recent weakness as they expect the company to benefit from growth in wireless data.

OTHER UPGRADES:

• UBS raised Weyerhaeuser (NYSE: WY) to Buy from Neutral.
  
• Credit Suisse upgraded MedCath (NASDAQ: MDTH) and Lululemon (NASDAQ: LULU) to Outperform from Neutral.
  
• Goldman added Cardinal Health (NYSE: CAH) to its Conviction Buy List.

MOST NOTEWORTHY: Washington Post, Harvest Natural, Memc Electronic Materials and Boston Private Financial were today's noteworthy upgrades:

• Deutsche Bank upgraded shares of The Washington Post Company (NYSE: WPO to Buy from Hold to reflect the company's exposure to the counter-cyclical education division.
• Jefferies upgraded shares of Harvest Natural Resources Inc. (NYSE: HNR) to Buy from Hold and raised their target to $17 from $11 after the company received final approval in the conversion to a mixed company. They note that conversion clears the way for renewed investment.
• Friedman Billings added Memc Electronic Materials Inc (NYSE: WFR) to its Top Picks List following its Q3 report and guidance as "solar wafer contracts," not including spot poly, are expected to increase from 15% of the total to 35%-40% in CY08 and greater than 50% in CY09.
• William Blair raised its rating on Boston Private Financial Holdings Inc (NASDAQ: BPFH) to Outperform from Market Perform after the better-than-expected Q3 results.

OTHER UPGRADES:

• Goldman added Dell Inc (NASDAQ: DELL) to its Conviction Buy List.
• NTT DoCoMo Inc (NYSE: DCM) was upgraded to Hold from Sell at Citigroup and to Buy from Neutral at UBS.
• Credit Suisse upgraded Cardinal Health Incorporated (NYSE: CAH) to Outperform from Neutral.
• Merrill upgraded Coca-Cola Femsa SA (NYSE: KOF) and Northeast Utilities (NYSE: NU) to Buy from Neutral.

MOST NOTEWORTHY: CyberSource, Century Casinos, Spectrum Pharm and Winnebago were today's noteworthy upgrades:

• JMP Securities upgraded shares of CyberSource (NASDAQ: CYBS) to Market Outperform from Market Perform citing valuation, positive management comments regarding BidPay, and incrementally positive industry checks on its fraud product.
  
• Brean Murray upgraded shares of Century Casinos (NASDAQ: CNTY) to Buy from Hold based on continued progress at recently opened properties, reduced Street expectations, and potential catalysts.
  
• Brean Murray also upgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) to Buy from Hold. The firm is highly confident that Spectrum's ozarelix will demonstrate similar efficacy and safety in the current U.S. Phase IIb trial and expects statistical significant. The firm expects Ph III initiations by year-end 2007 and Ph IIb data to be released on 2Q08.
  
• Winnebago Industries (NYSE: WGO) was upgraded to Outperform from Sector Perform at RBC Capital. The firm expects Winnebago to begin to post better earnings from more favorable mix and pricing in the 2008 model year.

OTHER UPGRADES:

• Merrill Lynch upgraded Cardinal Health (NYSE: CAH) to Buy from Neutral.
  
• Goldman upgraded shares of US Airways (NYSE: LCC) to Buy from Neutral.
  
• Avocent Corporation (NASDAQ: AVCT) was upgraded to Accumulate from Source the Funds at Think Equities.
  
• Collins Stewart raised Cyberonics (NASDAQ: CYBX) to Buy from Market Perform.

MOST NOTEWORTHY: GlaxoSmithKline plc (NYSE: GSK), Express Scripts, Inc (ESRX), SanDisk Corp (SNDK), Halliburton Co (HAL) and Texas Instruments (TXN) were some of today's noteworthy upgrades.

• Deutsche Bank upgraded GlaxoSmithKline plc (NYSE: GSK) to Buy from Hold.

• Express Scripts Inc (NASDAQ: ESRX) was upgraded to Strong Buy from Buy with a $113 target at First Albany, following the stronger-than-expected first quarter results.

• SanDisk Corp (NASDAQ: SNDK) was upgraded to Buy from Hold at Citigroup.

• Halliburton Co (NASDAQ: HAL) was added to AG Edwards Focus Portfolio. The firm believes Halliburton trades at a great discount to its largest peer, Schlumberger Ltd (SLB), despite an improved earnings outlook and progress on several issues.

• Texas Instruments (NASDAQ: TXN) was upgraded to Buy from Hold at Gabelli to reflect strong first quarter results and valuation. Piper Jaffray upgraded shares of Texas Instruments to Outperform from Market Perform...
  

OTHER UPGRADES:

• Keefe Bruyette upgraded shares of BancFirst Corp (NASDAQ: BANF) to Market Perform from Underperform following its first quarter report.

• Raymond James raised Cardinal Health, Inc (NYSE: CAH) to Outperform from Market Perform.

• Matrix USA raised H.B. Fuller Co (NYSE: FUL) to Hold from Sell based on the company's sales growth.

• Baird raised Snap-on Inc (NYSE: SNA) rating to Outperform from Neutral with a $55 target.

• Bear Stearns upgraded shares of Cummins Inc (NYSE: CMI) to Peer Perform from Underperform.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

MOST NOTEWORTHY: Under Armor Inc (NYSE: UA) and Cardinal Health Inc (NYSE: CAH) are today's most notable upgrades:

• Credit Suisse upgraded Under Armor Inc (NYSE: UA) to Outperform from Neutral with a $65 target and believes that the company is emerging as one of the premier global athletic brands.

• JMP Securities upgraded shares of Cardinal Health Inc (NYSE: CAH) to Outperform from Market Perform to reflect their expectation for accelerated earnings growth over the next three years.

OTHER UPGRADES:

• Friedman, Billings upgraded shares of Urban Outfitters Inc (NASDAQ: URBN) to Outperform from Market Perform to reflect positive momentum in URBN's core division, inventory control and easy upcoming comps.

• Stanford upgraded shares of Vonage Holdings (NYSE: VG) to Hold from Sell on valuation.

• Goldman Sachs upgraded the US Homebuilding Sector to Neutral from Sell saying the worst may be behind the group, but fundamentals remain troubling. The analyst said the next meaningful data will be from the Spring selling season, 6-8 weeks away.
• Goldman upgraded D.R. Horton Inc (NYSE: DHI), MDC Holdings Inc (NYSE: MDC) & Toll Brothers Inc (NYSE: TOL) to Buy from Neutral due to lower-risk at this point in the cycle. The Ryland Group Inc (NYSE: RYL) was upgraded to Neutral from Sell.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

MOST NOTEWORTHY: Kimberly Clark (KMB) and Amazon.com (AMZN) topped today's most notable upgrades:

• Prudential upgraded Kimberly Clark (NYSE: KMB) to Overweight from Underweight with an $80 target, reflecting lower commodity prices.
  
• Stifel upgraded Amazon.com (NASDAQ: AMZN) to Buy from Hold with a $44 target, noting that Amazon is entering an operating leverage cycle and usually performs well in such environments.

OTHER UPGRADES:

• Cowen considered bebe Stores's (NASDAQ: BEBE) risk/reward to be favorable at these levels, upgrading shares to Overweight from Neutral.
  
• Prudential upgraded shares of Citigroup Inc (NYSE: C) to Overweight from Neutral.
  
• Cardinal Health (NYSE: CAH) was upgraded to Overweight from Equal-Weight at Morgan Stanley.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Cardinal Health Inc. (NYSE: CAH) is the nation's number one supplier of support products and services for the health care industry. After a lengthy investigation by the New York Attorney General's office regarding the purchase of pharmaceutical products on the secondary pharmaceutical market, Cardinal Health announced December 26, 2006, that a settlement had been reached and that the situation is, for Cardinal, no longer an issue, except as pertains to their ongoing efforts to improve the security of the pharmaceutical products supply chain.

It should be noted that the $81 billion health provider Cardinal was only one participant in an investigation that involves health care players nation wide. Cardinal's stock value has deflated some over the past nine months, and may constitute a nice buy right about now.

The good news is that Cardinal has completed a comprehensive test of RFID technology, one of my pet projects. Cardinal has proven that RFID (radio frequency identification) tags can be applied to product, encoded en route, and then accurately read at normal production speeds during packaging and distribution of pharmaceuticals. The test has shown that RFID can be exploited within existing product flow models utilizing current equipment and materials. Cardinal reports encoding yields of 95% to 97%, and they expect they can fine tune for even higher yields. Yield simply means complete and accurate encoding in one production pass through.

MOST NOTEWORTHY: Whole Foods (WFMI), Sanofi-Aventis (SNY) and Isis Pharmaceuticals (ISIS) top today's list of initiations.

• Whole Foods Market, Inc. (NASDAQ:WFMI) was reinstated with an Outperform rating, raised from a Sector Perform rating, at RBC Capital Markets. The firm said expectations have been reduced and the risk/reward is favorable.
• Sanofi-Aventis (NYSE:SNY) was initiated with a Buy rating and $50 target at Bank of America. The firm is positive on Sanofi's late-stage pipeline beyond Acomplia.
• Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) was started with a Buy and $14 target at A.G. Edwards. The firm said Isis is at an inflection point and that potential commercial opportunity for the T5000 Biosensor has been "overlooked and undervalued by investors."

OTHER INITIATIONS:

• Citigroup assumed the coverage of Cardinal Health, Inc. (NYSE:CAH) with a Hold rating and $70 target.
• Bear Stearns initiated Western Union Co. (NYSE:WU) with an Outperform rating and $27 target. Bear Stearns said they are positive on Western Union's powerful brand name and unique global network.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).